TYO:2395 Revenue

In the fiscal year ending March 31, 2025, Shin Nippon Biomedical Laboratories had annual revenue of 32.41B JPY with 22.54% growth. Shin Nippon Biomedical Laboratories had revenue of 10.18B in the quarter ending March 31, 2025, with 20.22% growth.

Revenue

32.41B

Revenue Growth

+22.54%

P/S Ratio

1.75

Revenue / Employee

22.57M

Employees

1,436

Market Cap

56.62B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	32.41B	5.96B	22.54%
Mar 31, 2024	26.45B	1.36B	5.42%
Mar 31, 2023	25.09B	7.34B	41.37%
Mar 31, 2022	17.75B	2.64B	17.46%
Mar 31, 2021	15.11B	549.00M	3.77%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,222.12B
Takeda Pharmaceutical Company	4,581.55B
Daiichi Sankyo Company	1,886.26B
HOYA Corporation	866.03B
Terumo	1,036.17B
Otsuka Holdings	2,393.18B
Astellas Pharma	1,912.32B
Shionogi &	438.27B

Revenue Rankings